The use of tiagabine in pediatric spasticity management

Developmental Medicine and Child Neurology

Volumn 48, Issue 6, 2006, Pages 456-459

  Chu, Mary Lynn ^a,b   Sala, Debra A ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TIAGABINE;

ABDOMINAL PAIN; ANALGESIA; ANOREXIA; ARTICLE; ASTHENIA; ATTENTION DISTURBANCE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONCENTRATION LOSS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HOSTILITY; HUMAN; IRRITABILITY; MALE; MAXIMUM PERMISSIBLE DOSE; MOOD DISORDER; MOTOR DYSFUNCTION; MUSCLE FUNCTION; MYALGIA; PRIORITY JOURNAL; QUADRIPLEGIA; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; SPASTICITY; TREATMENT DURATION; TREATMENT OUTCOME;

ANTICONVULSANTS; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; NIPECOTIC ACIDS; PILOT PROJECTS; QUESTIONNAIRES; SELF CARE;

EID: 33646690216     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1017/S0012162206000983     Document Type: Article

References (14)

1. Albright AL, Cervi A, Singletary J. (1991) Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265: 1418-1422.
2. Boellner S, McCarty J, Mercante D, Sommerville K. (1996) Pilot study of tiagabine in children with partial seizures. Epilepsia 37 (Suppl 14): 92. (Abstract)
3. Bohannon RW, Smith MB. (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67: 206-207.
4. Haley SM, Coster WJ, Ludlow LH, Haltiwanger JT, Andrellos PJ. (1992) Pediatric Evaluation of Disability Inventory (PEDI), Version 1. Boston, MA: New England Medical Center-PEDI Research Group.
5. Harris SR, Smith LH, Krukowski L. (1985) Goniometric reliability for a child with spastic quadriplegia. J Pediatr Orthop 5: 348-351.
6. Holden KR, Titus MO. (1999) The effect of tiagabine on spasticity in children with intractable epilepsy: A pilot study. Pediatr Neurol 21: 728-730.
7. Leach JP, Brodie MJ. (1998) Tiagabine. Lancet 351: 203-207.
8. Novak V, Kanard R, Kissel JT, Mendell JR. (2001) Treatment of painful sensory neuropathy with tiagabine: A pilot study. Clin Auton Res 11: 357-361.
9. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. (1997) Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 39: 214-223.
10. Russell D, Rosenbaum P, Gowland C, Hardy S, Lane M, Plews N, McGavin H, Cadman D, Jarvis S. (1993) Gross Motor Function Measure Manual (2nd Edition). Hamilton, Ontario: McMaster University.
11. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S. (1989) The gross motor function measure: A means to evaluate the effects of physical therapy. Dev Med Child Neurol 81: 341-352.
12. Solaro C, Tanganelli P. (2004) Tiagabine for treating painful tonic spasms in multiple sclerosis: A pilot study. J Neurol Neurosurg Psychiatry 75: 341. (Letter)
13. Stuberg WA, Fuchs RH, Miedaner JA. (1998) Reliability of goniometric measurements of children with cerebral palsy. Dev Med Child Neurol 30: 657-666.
14. Uldall P, Bulteau C, Pedersen SA, Dulac O, Lyby K. (2000) Tiagabine adjunctive therapy in children with refractory epilepsy: A single-blind dose escalating study. Epilepsy Res 42: 159-168.